Back to Results
First PageMeta Content
Health / Orphan drugs / Depsipeptides / Prodrugs / Romidepsin / Pralatrexate / Cutaneous T-cell lymphoma / Food and Drug Administration / Peripheral T-cell lymphoma-Not-Otherwise-Specified / Medicine / Pharmacology / Lymphoma


U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may
Add to Reading List

Open Document

File Size: 146,57 KB

Share Result on Facebook
UPDATE